Log in to save to my catalogue

Patient activation and its association with symptom burden and quality of life across the spectrum o...

Patient activation and its association with symptom burden and quality of life across the spectrum o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_492e683162b14b24b1025aa3dfcec09d

Patient activation and its association with symptom burden and quality of life across the spectrum of chronic kidney disease stages in England

About this item

Full title

Patient activation and its association with symptom burden and quality of life across the spectrum of chronic kidney disease stages in England

Publisher

England: BioMed Central Ltd

Journal title

BMC nephrology, 2022-01, Vol.23 (1), p.45-45, Article 45

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The knowledge, skills, and confidence to manage one's own health is termed patient activation and can be assessed using the Patient Activation Measure (PAM). This measure is increasingly recommended for use in chronic kidney disease (CKD), but there is a need to better understand patient activation within this population. This work aimed to explore...

Alternative Titles

Full title

Patient activation and its association with symptom burden and quality of life across the spectrum of chronic kidney disease stages in England

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_492e683162b14b24b1025aa3dfcec09d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_492e683162b14b24b1025aa3dfcec09d

Other Identifiers

ISSN

1471-2369

E-ISSN

1471-2369

DOI

10.1186/s12882-022-02679-w

How to access this item